This article has a delayed release (embargo) and will be available in PMC on May 13, 2025.
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
Renée Maria Saliby, Chris Labaki, Tejas R Jammihal, Wanling Xie, Maxine Sun, Valisha Shah, Eddy Saad, M. Harry Kane, Soki Kashima, Katherine Sadak, Talal El Zarif, Deepak Poduval, Robert J Motzer, Thomas Powles, Brian I Rini, Laurence Albiges, Sumanta K Pal, Bradley A McGregor, Rana R McKay, Sabina Signoretti, Eliezer M Van Allen, Sachet A Shukla, Toni K Choueiri, David A Braun
Cancer Cell. Author manuscript; available in PMC 2025 May 13.
Published in final edited form as: Cancer Cell. 2024 May 13; 42(5): 732–735. Published online 2024 Apr 4. doi: 10.1016/j.ccell.2024.03.002
- PMCID:
- PMC11130783
Related Manuscript ID: NIHMS1993498
Reason: This article has a delayed release (embargo) and will be available in PMC on May 13, 2025. (An abstract of the
article is available in PubMed, which may also have a link to
the full text of the article at the publishing journal's website.)
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11130783/
Message ID: 596574459
Time: 2024/07/24 04:01:01
If you need further help, please write to the helpdesk. Include the information from the box above in your message.